Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.
Subscribe to see Next Frontier Biosciences, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Next Frontier Biosciences, LLC is a biotechnology company headquartered in Westminster, United States. It has raised at least $6.3M across the 4 funding rounds on record. Its most recent funding round raised $825,601 in January 2020.
As of 16 November 2026. Source: Xcout Intel.
At least $6.3M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $825,601 | — | |
| SEC Form D filing | $2.9M | — | |
| SEC Form D filing | $1.8M | — | |
| SEC Form D filing | $850,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Next Frontier Biosciences, LLC's closest competitors — see the full list of competitors and alternatives →
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These investigational HAVs are specifically crafted for universal compatibility, enabling easy implantation into any patient without inducing an immune rejection or an adverse foreign body response. Humacyte is currently building a pipeline of HAVs targeting the substantial market for vascular repair, reconstruction, and replacement. This includes applications such as treating vascular trauma, providing arteriovenous access for hemodialysis, addressing peripheral arterial disease, and facilitating coronary artery bypass grafting. Furthermore, the company is exploring the use of its HAVs for pediatric heart surgeries and for cellular therapeutic delivery, including the transplantation of pancreatic islet cells to manage Type 1 diabetes. Founded in 2004, Humacyte maintains its headquarters in Durham, North Carolina.
Precise Bio, Inc. is a clinical-stage regenerative medicine company that grows live organs for transplant using 3D bio-printing technology.
Truelastin Laboratories develops natural elastin biomaterials and product platforms for human health applications. The company serves the medical aesthetics and therapeutic sectors by creating tissue-engineered products and advanced drug delivery systems.
Tiger BioSciences is a medical technology company that specializes in regenerative medicine, developing cellular, acellular, and matrix-like products for wound care and aesthetic treatments. The company also manages human tissue recovery programs to supply biological materials for clinical applications. It serves healthcare providers and medical professionals globally.
BMI OrganBank is a medical device and biotechnology company developing next-generation organ and tissue transplant solutions.
CoreTissue BioEngineering Inc. is a biotechnology company headquartered in Yokohama, Japan, operating out of the Life Science Research Center. The company specializes in research, development, and regenerative medicine applications within the life sciences sector. It provides advanced biomedical engineering solutions from its Japanese laboratory headquarters.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Next Frontier Biosciences, LLC? Suggest a correction · Work at Next Frontier Biosciences, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.